Portal de Periódicos da CAPES

Transfusion safety: realigning efforts with risks

1997; Wiley; Volume: 37; Issue: 11-12 Linguagem: Inglês

10.1046/j.1537-2995.1997.37111298088055.x

1537-2995

AuBuchon Jp, Margot S. Kruskall,

Blood donation and transfusion practices

TransfusionVolume 37, Issue 11-12 p. 1211-1216 Transfusion safety: realigning efforts with risks J.P. AuBuchon, J.P. AuBuchon James P. AuBuchon, MD, Professor, Departments of Pathology and Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.Search for more papers by this authorM.S. Kruskall MD, Corresponding Author M.S. Kruskall MD DirectorDivision of Laboratory and Transfusion Medicine, and Associate Professor, Departments of Pathology and Medicine, Beth Israel Deaconess Medical Center, East Campus (Yamins-309), Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215.Search for more papers by this author J.P. AuBuchon, J.P. AuBuchon James P. AuBuchon, MD, Professor, Departments of Pathology and Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.Search for more papers by this authorM.S. Kruskall MD, Corresponding Author M.S. Kruskall MD DirectorDivision of Laboratory and Transfusion Medicine, and Associate Professor, Departments of Pathology and Medicine, Beth Israel Deaconess Medical Center, East Campus (Yamins-309), Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215.Search for more papers by this author First published: 09 October 2008 https://doi.org/10.1046/j.1537-2995.1997.37111298088055.xCitations: 45 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685–90. 2 AuBuchon JP, Birkmeyer JD, Busch M. Blood safety supply: opportunities and conundrums. Ann Intern Med 1997; 127: 904–9. 3 Linden JV, Paul B, Dressier KP. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601–6. 4 Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30: 583–90. 5 Honig CL, Bove JR. Transfusion-associated fatalities: review of Bureau of Biologics reports 1976–1978. Transfusion 1980; 20: 653–61. 6 Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev 1994; 8: 169–83. 7 Kessler DA. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA 1993; 269: 2765–8. 8 Greenberger PA. Plasma anaphylaxis and immediate type reactions. In: EC Rossi, TL Simon, GS Moss, SA Gould, eds. Principles of transfusion medicine. 2nd ed. Baltimore: Williams & Wilkins, 1996: 765–71. 9 Stack G, Judge JV, Snyder EL. Febrile and non-immune transfusion reactions. In: EC Rossi, TL Simon, GS Moss, SA Gould, eds. Principles of transfusion medicine. 2nd ed. Baltimore: Williams & Wilkins, 1996: 773–84. 10 McClelland DB, Phillips P. Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ 1994; 308: 1205–6. 11 Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens. Transfusion 1997; 37: 1169–72. 12 Murphy WG, McClelland DB. Deceptively low morbidity from failure to practice safe blood transfusion: an analysis of serious blood transfusion errors. Vox Sang 1989; 57: 59–62. 13 Wenz B, Burns ER. Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice. Transfusion 1991; 31: 401–3. 14 AuBuchon JP, Littenberg B. A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion. Transfusion 1996; 36: 222–6. 15 Jensen NJ, Crosson JT. An automated system for bedside verification of the match between patient identification and blood unit identification. Transfusion 1996; 36: 216–21. 16 Lenny LL, Hurst R, Zhu A, et al. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of Phase 1 trials. Transfusion 1995; 35: 899–902. 17 Lenny LL, Hurst R, Goldstein J, et al. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers. Blood 1991; 77: 1383–8. 18 Lenny LL, Hurst R, Goldstein J, Galbraith RA. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O. Transfusion 1994; 34: 209–14. 19 Lenny LL, Goldstein J. The production of group O cells. In: J Goldstein, ed. Biotechnology of blood. Boston: Butterworth-Heineman, 1991: 75–100. 20 Fricker J. Conversion of red blood cells to group O (news). Lancet 1996; 347: 680. 21 Murad K, Koumpouras F, Talbot M, et al. Molecular camouflage of antigenic determinants on intact mammalian cells: possible applications to transfusion medicine (abstract). Blood 1996; 88: 444a. 22 Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082–8. 23 Borden CW, Hall WH. Fatal transfusion reactions from massive bacterial contamination of blood. N Engl J Med 1951; 245: 760–5. 24 Högman CF, Gong J, Eriksson L, et al. White cells protect donor blood against bacterial contamination. Transfusion 1991; 31: 620–6. 25 Hogman CF, Engstrand L. Factors affecting growth of Yersinia enterocolitica in cellular blood products. Transfus Med Rev 1996; 10: 259–75. 26 Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991; 5: 73–83. 27 Katz L, MacPherson JL, Zuck TF. Yersinia and blood donation (letter). Transfusion 1992; 32: 191. 28 Grossman BJ, Kollins P, Lau PM, et al. Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica. Transfusion 1991; 31: 500–1. 29 Haditsch M, Binder L, Gabriel C, et al. Yersinia enterocolitica septicemia in autologous blood transfusion. Transfusion 1994; 34: 907–9. 30 Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33: 228–33. 31 Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994; 7: 290–302. 32 Bland LA, Villarino ME, Arduino MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardio-vasc Surg 1992; 103: 582–8. 33 Rumisek JD, Weddle RL. Autotransfusion in penetrating abdominal trauma. In: JM Hauer, RL Thurer, RB Dawson, eds. Autotransfusion. New York: Elsevier/North Holland, 1981: 105–13. 34 Padley D, Koontz F, Trigg ME, et al. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996; 36: 53–6. 35 Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991; 266: 555–8. 36 Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993; 33: 902–9. 37 Kim DM, Brecher ME, Bland LA, et al. Visual identification of bacterially contaminated red cells. Transfusion 1992; 32: 221–5. 38 Haverly RM, Harrison CR, Dougherty TH. Yersinia enterocolitica bacteremia associated with red blood cell transfusion. Arch Pathol Lab Med 1996; 120: 499–500. 39 Brecher ME, Hogan JJ, Boothe G, et al. Platelet bacterial contamination and the use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe. Transfusion 1994; 34: 750–5. 40 Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799–803. 41 Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993; 33: 754–65. 42 Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841–5. 43 Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372–6. 44 Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859–67. 45 Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573–8. 46 Bordin JO, Blajchman MA. Transfusion-associated immunosuppression. In: EC Rossi, TL Simon, GS Moss, SA Gould, eds. Principles of transfusion medicine. 2nd ed. Baltimore: Williams & Wilkins, 1996: 803–12. 47 Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328–33. 48 Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications. Transfusion 1994; 34: 714–27. 49 Vamvakas EC, Carven JH, Hibberd PL. Blood transfusion and infection after colorectal cancer surgery. Transfusion 1996; 36: 1000–8. 50 Thaler M, Shamiss A, Orgad S, et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 1989; 321: 25–8. 51 Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993; 33: 742–50. 52 Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989; 32: 749–53. 53 Steup WH, Brand A, Weterman IT, et al. The effect of perioperative blood transfusion on recurrence after primary operation for Crohn's disease. Scand J Gastroenterol Suppl 1991; 188: 81–6. 54 Unander AM. The role of immunization treatment in preventing recurrent abortion. Transfus Med Rev 1992; 6: 1–16. 55 Gatenby PA, Cameron K, Simes RJ et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 1993; 29: 88–94. 56 Lee TH, Ohto H, Paglieroni T, et al. Survival kinetics of specific donor leukocyte subsets in transfused immunocompetent patients (abstract). Transfusion 1996; 36(Suppl): 45S. 57 Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? (editorial) Transfusion 1997; 37: 121–5. 58 AuBuchon JP. Lessons learned from decision analysis. Transfusion 1996; 36: 755–60. Citing Literature Volume37, Issue11-12November‐December 1997Pages 1211-1216 ReferencesRelatedInformation